A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway

Hypoxia induces protective autophagy in glioblastoma cells and new therapeutic avenues that target this process may improve the outcome for glioblastoma patients. Recent studies have suggested that the autophagic process is upregulated in glioblastomas in response to extensive hypoxia. Hypoxia also...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Hao, Yuan, Guang, Guo, Xing, Liu, Qinglin, Zhang, Jinsen, Gao, Xiao, Guo, Xiaofan, Xu, Shugang, Li, Tong, Shao, Qianqian, Yan, Shaofeng, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Basic Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990999/
https://www.ncbi.nlm.nih.gov/pubmed/27163161
http://dx.doi.org/10.1080/15548627.2016.1178446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990999/
https://www.ncbi.nlm.nih.gov/pubmed/27163161
http://dx.doi.org/10.1080/15548627.2016.1178446

Ejemplares similares